BindingDB Data by Journal
PMID
Data
Article Title
Citation
Organization
Download Data
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition.

J Pharmacol Exp Ther 355: 397-409 (0)
Merck Research Laboratories